Bikker H, Vulsma T, Baas F, de Vijlder J J
Department of Pediatrics, Academic Medical Center, University of Amsterdam, The Netherlands.
Hum Mutat. 1995;6(1):9-16. doi: 10.1002/humu.1380060104.
Thyroid peroxidase (TPO) is the key enzyme in the synthesis of thyroid hormones. Defects in the TPO gene are reported to be the cause of congenital hypothyroidism due to a Total Iodide Organification Defect (TIOD). This type of defect, where iodide taken up by the thyroid gland cannot be oxidized and bound to protein, is the most common hereditary inborn error causing congenital hypothyroidism in the Netherlands. Denaturing Gradient Gel Electrophoresis (DGGE) of PCR amplified genomic DNA was used to screen for mutations in the TPO gene of TIOD patients from nine apparently unrelated families, and seven different mutations were detected. Three frameshift mutations were found: a 20 bp duplication in exon 2, a 4 bp duplication in exon 8, and an insertion of a single nucleotide (C) at pos. 2505 in exon 14. In addition, four single nucleotide substitutions were identified: one single-base mutation resulted in a premature termination codon (C-->T at pos. 1708 in exon 10), two single-base substitutions changed an amino acid in highly conserved regions of the gene (Tyr-->Asp in exon 9 and Glu-->Lys in exon 14). The fourth single-base mutation located at the exon 10/intron 10 border altered a conserved Gly into Ser and could also affect splicing. Nine TIOD patients from five families were compound heterozygotes and six patients from four families were homozygous for one of the mentioned mutations in the TPO gene.
甲状腺过氧化物酶(TPO)是甲状腺激素合成中的关键酶。据报道,TPO基因缺陷是导致先天性甲状腺功能减退症的原因,该病症由全碘有机化缺陷(TIOD)引起。这种类型的缺陷是指甲状腺摄取的碘无法被氧化并与蛋白质结合,在荷兰,这是导致先天性甲状腺功能减退症最常见的遗传性先天性疾病。通过对PCR扩增的基因组DNA进行变性梯度凝胶电泳(DGGE),对来自9个明显无亲缘关系家庭的TIOD患者的TPO基因进行突变筛查,共检测到7种不同的突变。发现了3种移码突变:外显子2中20 bp的重复、外显子8中4 bp的重复以及外显子14中第2505位插入单个核苷酸(C)。此外,还鉴定出4种单核苷酸替换:一种单碱基突变导致提前终止密码子(外显子10中第1708位C→T),两种单碱基替换改变了基因高度保守区域的氨基酸(外显子9中Tyr→Asp和外显子14中Glu→Lys)。位于外显子10/内含子10边界处的第4种单碱基突变将保守的甘氨酸变为丝氨酸,也可能影响剪接。来自5个家庭的9名TIOD患者为复合杂合子,来自4个家庭的6名患者为TPO基因上述突变之一的纯合子。